Leflunomide Market to Reach USD 1.12 Billion by 2032, Driven by...

added blog Other

2026-07-28 12:10:38 -

Leflunomide Market to Reach USD 1.12 Billion by 2032, Driven by Rising Prevalence of Rheumatoid Arthritis and Growing Demand for Cost-Effective Treatments

Global Leflunomide market, valued at approximately USD 634.2 Million in 2024, is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 7.3%, reaching an estimated USD 1.12 Billion by 2032. The market's expansion is fueled by rising prevalence of rheumatoid arthritis worldwide, growing demand for cost-effective treatments, aging populations in developed economies, improved...

0 Comments 0 Shares 4 Views 0 Reviews